The shareholder letter also details actions underway to reduce the Company’s cost base and better align spending with near-term priorities. These actions include workforce and facility optimization, tighter controls on corporate spending, and a more disciplined approach to capital allocation. Future capital raises will be linked to specific milestones rather than open-ended development programs. As part of this reset, the Company announces the departure of its Chief Science Officer, Colin van der Kuur. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.